Trump's decision to move marijuana to Schedule III could ease taxes and expand medical access, but industry leaders warn it ...
The U.S. Supreme Court is declining to take up a case challenging the constitutionality of federal marijuana prohibition—an ...
CNBC reminded readers that, despite the latest surge, cannabis shares remain well below past peaks: Tilray recently traded at ...
A report stating that the administration is close to reclassifying cannabis as a Schedule III drug has the $32 billion ...
Congressional candidate pledges legalization bill on 1st day; AK psychedelics initiative; Study: Legal marijuana reduces ...
The review also found that daily use of medical cannabis — especially inhaled or high-potency products — may increase the ...
The move would not legalize or decriminalize marijuana, but it would ease barriers to research and boost the bottom lines of ...
Shares of cannabis companies jumped on Friday after the Washington Post reported U.S. President Donald Trump is expected to ...
The Post Dispensary in Beaver Dam becomes Kentucky's first fully-licensed medical marijuana facility, with Gov. Beshear ...